Injectables & Biologics in Musculoskeletal Care

Injectable Therapies at Spinal & Sports Care

Injectable therapies offer targeted ways to modulate pain, inflammation, and tissue repair. At Spinal & Sports Care, we treat these therapies as adjuncts to movement, rehabilitation, load management, and manual therapy—not stand-alone fixes. Patient selection, diagnosis, imaging guidance, and post-injection rehabilitation are crucial to achieving safe and effective outcomes.

Platelet-Rich Plasma (PRP)

What It Is & Mechanism:

PRP is made from the patient’s own blood. After centrifugation, platelets and growth factors are concentrated and injected into target tissues. The purpose: deliver a higher local dose of signalling molecules that may stimulate angiogenesis, fibroblast proliferation, collagen synthesis, and modulation of inflammation. Some in vitro and animal studies show how PRP can “reset” chronic tendon pathology by suppressing pro-inflammatory cytokines (e.g., IL-1) and promoting matrix remodelling.

Clinical Evidence: Strengths & Limits

• In randomised controlled trials for tendinopathy, PRP has shown a moderate effect size in reducing pain compared to control injections at follow-up periods of 3 months or longer.
• A recent meta-analysis comparing PRP with corticosteroids in tendinopathy (encompassing conditions such as rotator cuff, lateral epicondylitis, and plantar fasciitis) found PRP to have better medium-term outcomes and fewer recurrences than corticosteroids.
• That said, many trials employ mixed protocols, with variations in platelet count, leukocyte content, activation method, injection volume, and rehabilitation plan, making comparisons challenging. A 2025 narrative review emphasises the importance of dosing, leukocyte content, and protocol standardisation.
• In rotator cuff tendinopathy, specifically, systematic reviews have found short-term pain relief and functional improvement. Still, the long-term advantage over a placebo or steroid is less clear.

Best Use & Considerations

• PRP tends to work best in chronic tendon or soft tissue injuries that have failed conservative care
• It is less certain in heavily degenerated tissue or in advanced osteoarthritis alone.
• Ultrasound guidance often improves accuracy and safety
• Soreness flare, 1–3 days post-injection, is common
• Because of variability in protocols, patient expectations should be realistic

Mesenchymal Stem / Progenitor Cell Therapies

What They Are

These are cells harvested (e.g., from bone marrow, adipose fat) that are believed to modulate inflammation, produce trophic factors, and possibly differentiate into cartilage, ligament, or other tissues. Their appeal lies in their regenerative potential and immunomodulatory effects, rather than simply providing symptomatic relief.

What the Evidence Shows

• A study found that intra-articular mesenchymal stem cells (MSC) and PRP often outperformed hyaluronic acid and saline in knee osteoarthritis in terms of pain and function.
• However, reviews of stem cell injections for knee OA (across several trials) caution high risk of bias, small sample sizes, inconsistencies in cell processing, and heterogeneity of patient populations.
• Some early reports on tendon, ligament, and meniscal repair show promise, but long-term durability remains under study.

Risks, Limitations & Practical Matters

• Cost is high, and insurance coverage is often limited
• Lack of standardisation in cell dose, viability, delivery method, and adjunct therapy
• Regulatory oversight is rigorous — many jurisdictions limit use to research settings
• Outcomes depend heavily on rehabilitation, mechanical stimulus, and patient factors

Corticosteroid Injections

Immediate Role

Steroid injections are anti-inflammatory agents delivered locally to calm pain flares in joints, bursae, or tendon sheaths. They are often used when inflammation is limiting a patient’s ability to engage in therapy.

Evidence & Duration of Effect

• Numerous randomised trials support their short-term effectiveness for pain and symptom relief in degenerative joint disease, bursitis, and impingement syndromes.
• The effect is typically strongest in the first few weeks; for many patients, benefit wanes by 3–4 months.
• Repeated or frequent injections carry the risk of cartilage thinning, tendon weakening, and tissue degeneration.

Best Use & Risks

• Use is best reserved for episodes severe enough to derail rehab
• Limit frequency to preserve tissue health
• Risks: injection flare, infection, local tissue damage, systemic steroid effects (blood sugar, adrenal suppression)
• Must be guided carefully and combined immediately with rehabilitation

Hyaluronic Acid Injections (Viscosupplementation, e.g. SynVisc)

Summary

Hyaluronic acid injections introduce a gel-like lubricant into the joint, aiming to improve joint lubrication, shock absorption, and reduce mechanical pain. The procedure may include first draining excess fluid, using a local anesthetic, and then injecting once or as a short series.

What Recent Research Suggests

• When compared to placebo, many meta-analyses show only modest benefit — small reductions in pain and improvements in function, often temporary.
• Systematic reviews caution that the difference over placebo is small, and some patients experience injection flare reactions.
• The benefit is more likely in earlier-stage disease rather than in severely degenerated joints.

Clinical Considerations

• Not a cure, & symptom relief may last a few months
• Risks include mild swelling, pain flare, and rare infection
• Benefit is best when combined with load management, strength & mobility work
• Realistic expectations are essential

Peptides & Biologic Compounds (TB-500, BPC-157, “Wolverine Stack”)

Mechanisms & Research

• Peptides are small proteins that act as signalling molecules. Early research suggests that some peptides (e.g., BPC-157, TB-500) may influence angiogenesis, cell migration, inflammatory modulation, and extracellular matrix repair in animal models, assisting in healing response times.
• Some laboratory and in vivo preclinical studies propose that combining peptides with MSCs or hyaluronic acid may synergistically augment tissue healing.

Key Peptides

• TB-500 (a synthetic analogue of Thymosin Beta-4) is purported to promote actin regulation, cell migration, and tissue regeneration. But human clinical data are lacking.
• BPC-157 has been studied in animal models for tendon, ligament, nerve, and gut repair, showing promising effects in controlled experiments.
• The term “Wolverine Stack” refers to combining these and other growth peptides to maximise effects — but this is largely speculative and unproven in human trials.

Legal & Safety Warnings (especially in Australia)

• Many peptides are not approved for human therapeutic use in Australia
• Use without a prescription or outside controlled settings may be illegal
• Safety profiles are not established. Risks may include unregulated dosing, off-target growth, immune response, or unknown long-term outcomes
• We do not offer peptides as a therapeutic option. Still, we may discuss them in a research or specialist context with full informed consent to address patient questions.

Summary Table

Comparison of major injectables:

Summary Table of Injectable Therapies

What to Expect in the Clinic

• Thorough evaluation with imaging (if needed) to localise pathology
• Clear discussion of risks, benefits, and the strength of evidence of all care and procedures that may be considered throughout your care
• Referral to a sports doctor or specialist for injection where appropriate. This will be assessed by a specialist on consultation and performed using image guidance when indicated.
• Immediate rehabilitation plan to “capitalise” on the biological window
• Close follow-up and reassessment, with fallback to alternative treatments if an insufficient response is observed, including reassessment for the specialist medical team.

Post-Injection Care & Rehabilitation

After any injectable treatment, post-injection care is critical to achieving the best outcomes. Evidence suggests that structured rehabilitation following injections leads to improved pain relief, enhanced function, and better long-term recovery. General recommendations include:

• Activity modification: Avoid strenuous activity for 24–48 hours after most injections
• Pain management: Temporary soreness at the injection site is common; ice and mild analgesics can be used.
• Gradual loading: A progressive return to exercise under the guidance of physiotherapists ensures tissue adaptation.
• Structured rehabilitation: Tendon and joint injections benefit from eccentric strengthening, mobility exercises, and sport-specific retraining over several weeks.
• Clinical follow-up: Regular reviews help track progress and address any adverse responses early.

Research highlights that injections alone rarely provide lasting benefit without complementary rehabilitation. Our clinic integrates post-injection therapy with physiotherapy, strength and conditioning, and injury prevention programs to optimise recovery and reduce re-injury risk.